Advertisement

Cytogenetic Nomenclature and Reporting

  • Marian Stevens-KroefEmail author
  • Annet Simons
  • Katrina Rack
  • Rosalind J. Hastings
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1541)

Abstract

A standardized nomenclature is critical for the accurate and consistent description of genomic changes as identified by karyotyping, fluorescence in situ hybridization and microarray. The International System for Human Cytogenomic Nomenclature (ISCN) is the central reference for the description of karyotyping, FISH, and microarray results, and provides rules for describing cytogenetic and molecular cytogenetic findings in laboratory reports. These laboratory reports are documents to the referring clinician, and should be clear, accurate and contain all information relevant for good interpretation of the cytogenetic findings. Here, we describe guidelines for cytogenetic nomenclature and laboratory reports for cytogenetic testing applied to tumor samples.

Key words

Karyotyping FISH Microarray Nomenclature Diagnostic reports 

References

  1. 1.
    Heim S, Mittelman F (eds) (2015) Cancer cytogenetics: chromosomal and molecular genetic aberrations of tumor cells, 4th edn. Wiley-Blackwell, LondonGoogle Scholar
  2. 2.
    McGowan-Jordan J, Simons A, Schmid M (eds) (2016) An international system for human cytogenomic nomenclature. S. Karger, Basel. [Reprint of Cytogenet Genome Res 149(1–2)]Google Scholar
  3. 3.
    Hastings RJ, Cavani S, Bricarelli FD, ECA PWG Co-ordinators et al (2007) Cytogenetic Guidelines and Quality Assurance: a common European framework for quality assessment for constitutional and acquired cytogenetic investigations. Eur J Hum Genet 15:525–527CrossRefPubMedGoogle Scholar
  4. 4.
    Dawson AJ, McGowan-Jordan J, Chernos J et al (2011) Canadian College of Medical Geneticists guidelines for the indications, analysis, and reporting of cancer specimens. Curr Oncol 18:e250–e255PubMedPubMedCentralGoogle Scholar
  5. 5.
    Claustres M, Kožich V, Dequeker E et al (2013) European Society of Human Genetics. Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet 22:160–170. doi: 10.1038/ejhg.2013.125 CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hastings RJ, Brown N, Tibiletti MG et al (2016) Guidelines for cytogenetic investigations in tumours. Eur J Hum Genet 24:6–13. doi: 10.1038/ejhg.2015.35 CrossRefPubMedGoogle Scholar
  7. 7.
    Schoumans J, Suela J, Hastings R et al (2016) Guidelines for genomic array analysis in acquired haematological neoplastic disorders. Genes Chromosomes Cancer 55:480–491. doi: 10.1002/gcc.22350 CrossRefPubMedGoogle Scholar
  8. 8.
    Simons A, Sikkema-Raddatz B, de Leeuw N et al (2012) Genome-wide arrays in routine diagnostics of hematological malignancies. Hum Mutat 33:941–948. doi: 10.1038/ejhg.2015.35 CrossRefPubMedGoogle Scholar
  9. 9.
    Hanson CA, Steensma DP, Hodnefield JM et al (2008) Isolated trisomy 15: a clonal chromosome abnormality in bone marrow with doubtful hematologic significance. Am J Clin Pathol 129:478–485CrossRefPubMedGoogle Scholar
  10. 10.
    Goswami RS, Liang CS, Bueso-Ramos CE et al (2015) Isolated +15 in bone marrow: disease-associated or a benign finding? Leuk Res 39:72–76CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media LLC 2017

Authors and Affiliations

  • Marian Stevens-Kroef
    • 1
    Email author
  • Annet Simons
    • 1
  • Katrina Rack
    • 2
  • Rosalind J. Hastings
    • 2
  1. 1.Department of Human GeneticsRadboud University Medical CenterNijmegenThe Netherlands
  2. 2.Cytogenetic External Quality Assessment, Women’s Centre, John Radcliffe HospitalOxford University Hospitals NHS Foundation TrustOxfordUK

Personalised recommendations